These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population. Chin BS, Futaba K, Jethwa A, Lip GY. Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070 [Abstract] [Full Text] [Related]
12. Lessons learned from the WHI: HRT requires a cautious and individualized approach. Aubuchon M, Santoro N. Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157 [Abstract] [Full Text] [Related]
13. Hormone replacement therapy in postmenopausal women. Yasui T, Uemura H, Takikawa M, Irahara M. J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382 [Abstract] [Full Text] [Related]
14. [Cardiovascular risk and hormone replacement therapy in menopause]. Plu-Bureau G. Therapie; 1999 Aug; 54(3):375-80. PubMed ID: 10500454 [Abstract] [Full Text] [Related]
15. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD. Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [Abstract] [Full Text] [Related]
18. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC. Maturitas; 2005 Jun 16; 51(2):113-26. PubMed ID: 15917151 [Abstract] [Full Text] [Related]
19. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts]. Motolese M. Ital Heart J Suppl; 2003 Jul 16; 4(7):545-58. PubMed ID: 14558283 [Abstract] [Full Text] [Related]
20. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease. Lowe GD. J Intern Med; 2004 Nov 16; 256(5):361-74. PubMed ID: 15485471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]